Dentsply Sirona Revised FY23 Organic Sales Growth Of Approximately 1%, With Sales Of $3.90B-$3.94B Compared To Prior Guidance Of Around 3% And Consensus Of $4.01B
Portfolio Pulse from Benzinga Newsdesk
Dentsply Sirona has revised its FY23 organic sales growth to approximately 1%, with sales of $3.90B-$3.94B, compared to prior guidance of around 3% and consensus of $4.01B. The company's adjusted EPS is expected to be in the range of $1.80 to $1.85.
November 02, 2023 | 10:22 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Dentsply Sirona has lowered its FY23 sales growth forecast, which could negatively impact its stock price.
Dentsply Sirona has revised down its FY23 sales growth forecast, which is lower than the consensus. This could lead to a negative sentiment among investors, potentially causing a drop in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100